Company Filing History:
Years Active: 2000-2008
Title: A Profile of Inventor Angela Hilary Atkinson
Introduction
Angela Hilary Atkinson is an esteemed inventor based in Montrose, Australia, recognized for her significant contributions to the field of biotechnology. With a remarkable portfolio of nine patents, Atkinson's work centers on proteinase inhibitors and genetic sequences, addressing important challenges in the scientific and agricultural communities.
Latest Patents
Among her notable inventions, Atkinson has recently developed patents focused on proteinase inhibitors. One of her key patents is titled "Proteinase inhibitor, precursor thereof and genetic sequences encoding same." This invention deals with a nucleic acid molecule comprising a sequence of nucleotides that encodes a type II serine proteinase inhibitor precursor from a plant. It highlights the design of a precursor comprising at least three PI monomers, where one of the monomers possesses a chymotrypsin-specific site and another has a trypsin-specific site.
Another significant patent by Atkinson is "Isolated monomers of a type II serine proteinase inhibitor." This patent continues her exploration of proteinase inhibitors and their applications in biotechnology, showcasing her innovative approach to isolating monomers of these critical inhibitors.
Career Highlights
Angela Atkinson has had a productive career in both commercial and academic sectors. She has played an integral role at Hexima Limited, a biotechnology company that specializes in developing innovative solutions for agriculture and health. Additionally, Atkinson has collaborated with the prestigious University of Melbourne, further enhancing her reputation as a leading inventor in her field.
Collaborations
Throughout her career, Atkinson has worked alongside esteemed colleagues such as Marilyn Anne Anderson and Robyn Louise Heath. These collaborations have broadened her research scope and led to further advancements in proteinase inhibitor technologies, underlining the importance of teamwork in scientific innovation.
Conclusion
Angela Hilary Atkinson's contributions to the field of biotechnology, particularly through her patents on proteinase inhibitors, demonstrate her commitment to advancing scientific knowledge and innovation. Her work, backed by collaborations with notable companies and research institutions, exemplifies the impact of dedicated inventors in addressing the complexities of modern biological sciences. As she continues to develop new technologies, Atkinson stands as an inspiring figure in the landscape of invention and innovation.